Filing Details

Accession Number:
0001493152-21-030337
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-02 18:30:14
Reporting Period:
2021-12-01
Accepted Time:
2021-12-02 18:30:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1433607 Inspiremd Inc. NSPR Surgical & Medical Instruments & Apparatus (3841) 262123838
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1528577 Paul Stuka C/O Inspiremd, Inc.
4 Menorat Hamaor St.
Tel Aviv L3 6744832
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-01 12,037 $3.51 73,534 No 4 P Indirect See Note
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Note
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 42,320 Direct
Footnotes
  1. These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.49 to $3.52, inclusive. The Reporting Person undertakes to provide to InspireMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).